Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | MYGN Myriad Genetics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $4.17 +0.7% | $14.86 -2.5% |
| StockIQ Score | 50C- Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 67B- | 13F |
| Fundamental | 39F | 35F |
| Growth | 32F | 50C- |
| Fair Value | 50C- | 38F |
| News | 44D | 50C- |
| Quality | 63C+ | 50C- |
| Risk | 46D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
MYGN scores higher than AAPG on investor (40 vs 39), technical (38 vs 24), fundamental (39 vs 35) and valuation (50 vs 38) metrics. AAPG, however, has a stronger growth score at 50 compared with MYGN’s 32.
